VOR vs. ENTA
VOR (Vor Biopharma Inc.) and ENTA (Enanta Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, VOR returned -49.22%/yr vs -24.07%/yr for ENTA. At a 0.29 correlation, their price movements are largely independent.
Performance
VOR vs. ENTA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VOR achieves a 9.79% return, which is significantly higher than ENTA's -24.54% return.
VOR
- 1D
- 1.92%
- 1M
- -9.74%
- YTD
- 9.79%
- 6M
- 14.79%
- 1Y
- 246.86%
- 3Y*
- -48.18%
- 5Y*
- -49.22%
- 10Y*
- —
ENTA
- 1D
- 3.39%
- 1M
- -15.18%
- YTD
- -24.54%
- 6M
- -19.21%
- 1Y
- 60.59%
- 3Y*
- -21.72%
- 5Y*
- -24.07%
- 10Y*
- -6.52%
VOR vs. ENTA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 9.79% | -41.08% | -50.67% | -66.17% | -42.77% | -72.35% |
ENTA Enanta Pharmaceuticals, Inc. | -24.54% | 174.26% | -38.89% | -79.77% | -37.79% | 42.17% |
Correlation
The correlation between VOR and ENTA is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Feb 5, 2021 | 0.29 |
Fundamentals
VOR:
$617.65M
ENTA:
$343.81M
VOR:
-$53.66
ENTA:
-$2.67
VOR:
$0.00
ENTA:
$69.21M
VOR:
-$23.00K
ENTA:
$33.44M
VOR:
-$1.13B
ENTA:
-$61.85M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VOR vs. ENTA — Risk / Return Rank
VOR
ENTA
VOR vs. ENTA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Enanta Pharmaceuticals, Inc. (ENTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VOR | ENTA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.89 | ||
| Sortino ratioReturn per unit of downside risk | +1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.27 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.85 | 1.78 | +1.08 |
| Martin ratioReturn relative to average drawdown | 4.09 | 3.36 | +0.73 |
Loading charts...
Drawdowns
VOR vs. ENTA - Drawdown Comparison
The maximum VOR drawdown since its inception was -99.72%, roughly equal to the maximum ENTA drawdown of -96.63%. Use the drawdown chart below to compare losses from any high point for VOR and ENTA.
Loading charts...
Drawdown Indicators
| VOR | ENTA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -96.63% | -3.09% |
Max Drawdown (1Y)Largest decline over 1 year | -87.15% | -34.30% | -52.85% |
Max Drawdown (3Y)Largest decline over 3 years | -97.03% | -82.38% | -14.65% |
Max Drawdown (5Y)Largest decline over 5 years | -99.32% | -95.62% | -3.70% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.63% | — |
Current DrawdownCurrent decline from peak | -98.67% | -90.58% | -8.09% |
Average DrawdownAverage peak-to-trough decline | -88.69% | -49.27% | -39.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.71% | 18.11% | +42.60% |
Volatility
VOR vs. ENTA - Volatility Comparison
Vor Biopharma Inc. (VOR) has a higher volatility of 23.24% compared to Enanta Pharmaceuticals, Inc. (ENTA) at 13.67%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than ENTA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VOR | ENTA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.24% | 13.67% | +9.57% |
Volatility (6M)Calculated over the trailing 6-month period | 68.60% | 35.48% | +33.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 171.72% | 109.73% | +61.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.35% | 73.36% | +42.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 116.73% | 60.69% | +56.04% |
Dividends
VOR vs. ENTA - Dividend Comparison
Neither VOR nor ENTA has paid dividends to shareholders.
Financials
VOR vs. ENTA - Financials Comparison
This section allows you to compare key financial metrics between Vor Biopharma Inc. and Enanta Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VOR and ENTA have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VOR has higher volatility (23.24%) compared to ENTA (13.67%). In terms of maximum drawdown, VOR dropped -99.72% vs ENTA's -96.63%.
VOR currently has the higher Sharpe Ratio (1.45 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VOR and ENTA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer